Fecal microbiota transplantation helps 21-year-old man bid farewell to years of gastrointestinal distress

Release time:2025-08-02
views:545
Intestinal Microecology Diagnosis and Treatment Center

Mr. Li, 21 years old, has been troubled by symptoms such as frequent diarrhea and excessive flatulence for many years. Despite seeking treatment from various places, the results have been minimal, seriously affecting his normal work and life.

Not long ago, Li, who had suffered from gastrointestinal discomfort for many years, received fecal microbiota transplantation treatment by the team led by Zhao Xinkai, the vice president of Hainan Cancer Hospital and director of the Intestinal Microecology Diagnosis and Treatment Center of Hainan Chengmei Hospital. After systematic treatment, his symptoms improved.

Suffering from chronic gastrointestinal disorders, which seriously affect work and life.

Mr. Li, who is 21 years old, is in the prime of his youth but has been plagued by gastrointestinal problems for a long time.

Mr. Li said helplessly, "My stomach was always uncomfortable before. I would have diarrhea whenever I was nervous. I kept passing gas all day long, which was really embarrassing. I didnt even want to go out of the door." He has been suffering from stubborn gastrointestinal diseases for many years. Not only did he dare not participate in normal social activities, but he also stayed indoors all day long, gradually becoming anxious and sensitive.

After examination, Mr. Li was diagnosed with gastrointestinal dysfunction. He has tried various treatments such as probiotics and traditional Chinese medicine, but there has been no improvement.

In May this year, upon recommendation, he sought further treatment from the team led by Director Zhao Xinkai.

After undergoing routine stool tests, colonoscopy and intestinal function tests and other relevant examinations, Mr. Li was finally diagnosed with irritable bowel syndrome. Director Zhao Xinkai introduced that irritable bowel syndrome (IBS) is a common functional bowel disease, with abdominal pain, abdominal distension, changes in bowel habits and stool consistency as the main clinical manifestations, and the symptoms recur frequently. Current medical research shows that intestinal flora imbalance is regarded as one of the key factors triggering irritable bowel syndrome.

Conventional treatment methods for irritable bowel syndrome, such as dietary adjustments and medication (antispasmodics, antidiarrheals, probiotics, etc.), have limited effects on some patients, especially those with irritable bowel syndrome caused by dysbiosis. Traditional therapies are difficult to address the root cause. Fecal microbiota transplantation, by restoring the balance of the intestinal microecology in patients, offers a new treatment approach for such patients. After thorough communication with Mr. Li, Dr. Zhao Xinkais team decided to implement fecal microbiota transplantation for him.

Fecal microbiota transplantation cures stubborn diseases; 21-year-old regains confidence in life.

After meticulous preparation, the team led by Director Zhao Xinkai successfully performed a microbiota transplantation surgery on Mr. Li. During the postoperative recovery period, the medical team closely monitored the colonization of Mr. Lis intestinal microbiota. "From the monitoring data, Mr. Lis microbiota colonization is quite good," Director Zhao Xinkai said, which has laid a solid foundation for the improvement of his symptoms.

Mr. Li also truly felt the changes in his body. "Since I received the microbiota transplantation, I feel that the symptoms of diarrhea and flatulence have improved a lot." The relief of the stubborn disease that had troubled him for many years has restored his confidence in returning to a normal life.

Director Zhao Xinkai emphasized that the core of fecal microbiota transplantation lies in restoring the intestinal microecological balance of patients by transplanting healthy intestinal flora, thereby improving various intestinal functional disorders caused by microbial imbalance.

Precision diagnosis and treatment safeguard intestinal health.

Director Zhao Xinkai reminds us that the imbalance of intestinal flora is closely related to multiple systemic diseases throughout the body. It not only causes digestive system disorders but may also affect the cardiovascular, nervous, immune systems and even increase the risk of cancer.

As the first intestinal microecology diagnosis and treatment center in Hainan, the Intestinal Microecology Diagnosis and Treatment Center of Hainan Chengmei Hospital centers on patients and implements a "multi-disciplinary integration and joint management" diagnosis and treatment model. The center offers novel clinical diagnostic techniques such as intestinal barrier function assessment, fecal microbiota analysis, and intestinal microbiota analysis, as well as new treatment technologies including fecal microbiota transplantation via the lower digestive tract, formula probiotic capsules, and multi-dimensional microecological nutritional intervention. The service scope covers patients with diseases in multiple fields including digestion, cardiovascular, nervous system, tumors, immunity, infectious diseases, and skin diseases.

The Intestinal Microecology Diagnosis and Treatment Center offers appointment-based outpatient services.

Doctors assistant: 13226895419

Central visiting experts

Zhao Xinkai, Chief Physician

Vice President of Hainan Cancer Hospital

Director of the Intestinal Microecology Diagnosis and Treatment Center

Medical expertise

Proficient in various complex and difficult techniques of digestive endoscopy, such as ERCP and related techniques, ESD and related techniques, endoscopic ultrasound technology, PEG technology, capsule endoscopy technology, small intestine endoscopy technology, and various other endoscopic diagnosis and treatment techniques.

Vice President Yang Shufen

Chief Physician, Professor

Postgraduate supervisor, expert in child health care

Medical expertise

Having been deeply engaged in childrens health care for over 30 years, I am proficient in providing guidance on childrens nutrition and feeding, monitoring and evaluating childrens growth and development, especially in the management of childrens height.

Zheng Yin

Vice President, Chief Physician, Professor

Vice President, Masters Degree, Chief Physician

Professor, Masters Supervisor

Scholar in the United States, Leading Talent of Hainan Province

Outstanding Experts with Distinguished Contributions in Hainan Province

Medical expertise

Proficient in the prevention, diagnosis, treatment, rehabilitation and health management of cardiovascular and cerebrovascular diseases and geriatric diseases. Specialized in cardiac rehabilitation for patients with hypertension, coronary heart disease, arrhythmia, heart failure, metabolic syndrome, after stent implantation and bypass surgery, including guidance on medication, exercise, nutrition and sleep disorders.

Lin Haifeng, Chief Physician

Director of the Third Department of Oncology Internal Medicine

Medical expertise

Proficient in the diagnosis and treatment of oncology, such as lung cancer, lung nodules, breast cancer, liver tumors, liver nodules, digestive tract tumors, head and neck tumors, urinary system tumors, etc., as well as early screening, ablation treatment and full-course management of advanced liver cancer; rich experience in the diagnosis and treatment of difficult cases of malignant tumors, and familiar with the application of medical lifestyle in malignant tumors.

Dai Wenxin, Chief Physician

Professor, Doctoral Supervisor, Postdoctoral Supervisor, and Masters Supervisor of the Executive Director of the Multidisciplinary Diagnosis and Treatment Center for Geriatrics

Medical expertise

I. Diagnosis and treatment of Alzheimers disease and other geriatric diseases;

II. Diagnosis and treatment of multi-disciplinary diseases such as respiratory system, cardiovascular system, nervous system, and geriatric diseases;

III. Genetic diagnosis of tumors and integrated precision treatment including chemotherapy, targeted therapy, immunotherapy, microenvironmental therapy.

IV. Genetic diagnosis and precise treatment of hypertension, hyperlipidemia, hyperuricemia and hyperglycemia;

V. New biomedical technologies such as stem cells and gene programming, new technologies like insulin pumps and diabetes reversal; 

VI. High-intensity focused ultrasound (HIFU) for treating both benign and malignant tumors.

VII. Microbial Therapy of Intestinal Flora for Chronic Diseases and Mental Disorders

VIII. Diagnostic and therapeutic techniques under bronchoscopy, mediastinoscopy, thoracoscopy and other internal medicine endoscopy;

IX. Sleep Medicine

X. Chronic Disease Management.

Article | Huang Fei